Clinical trial Recruiting at 1 site Interventional Ages 12 to 19

Bright light therapy for adolescents with depression who are evening-types

Official title: Bright Light Therapy for Adolescents With Depression and Eveningness - a Randomized, Placebo-controlled, Assessor-blinded Study

Run by Chinese University of Hong Kong · NCT06973759 · Data updated 2026-11-12

This will see if daily bright light therapy helps Chinese teens (ages 12–19) with non-seasonal unipolar depression who are evening-types.

Quick facts

Study typeInterventional
Ages12 Years to 19 Years
SexAll
Enrollment90 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Hong Kong, Hong Kong)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedJune 30, 2028
Study endsJune 30, 2028
Registry record updatedMarch 19, 2026
Trial IDNCT06973759 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Chinese adolescents aged 12–19 with DSM-5 unipolar non-seasonal depression, CDRS-R ≥ 40, and an rMEQ score < 12 who do not have bipolar history, psychosis, intellectual disability, or active substance dependence.

Probably not a fit

Patients with bipolar disorder, schizophrenia spectrum disorders, intellectual disability, active substance dependence, or clinically significant suicidality are excluded and would not be expected to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, placebo-controlled, assessor-blinded trial at the Chinese University of Hong Kong compares daily bright light therapy to dim red light (placebo) in adolescents with unipolar non-seasonal depression and an evening chronotype. Eligible participants aged 12–19 who meet DSM-5 criteria for unipolar depression and have an rMEQ score < 12 are randomized to eight weeks of daily light treatment. Depression severity (CDRS-R), sleep parameters, and circadian markers are measured at baseline, during treatment, after eight weeks, and at follow-up. Key exclusions include bipolar or psychotic disorders, intellectual disability, active substance dependence, and clinically significant suicidality.

Why it matters

Potential benefit: If successful, bright light therapy could offer a low-risk, non-drug option to improve mood and shift sleep timing in evening-type adolescents with depression.

How similar studies have gone: Bright light therapy has clear benefits for seasonal depression and some positive results in adults with non-seasonal depression, but its use specifically in adolescents with eveningness is relatively novel and evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Chinese, aged 12-19 years old;
2. Written informed assent/consent of participation into the study is given by the participant and his/her parent or guardian (for those aged under 18), respectively;
3. Having a DSM-5 diagnosis of unipolar non-seasonal depression as confirmed by the Chinese version of the Kiddie-Schedule for Affective Disorders and Schizophrenia (K-SADS) psychiatric interview, DSM-5 Seasonal specifier, AND having a score on Children's Depression Rating Scale (CDRS-R) at least 40;
4. Being classified as evening chronotype according to the score on the reduced Horne-Östberg Morning-Eveningness Questionnaire (rMEQ), i.e. \<12.

Exclusion Criteria:

1. A current diagnosis of substance abuse or dependence; a current or past history of manic or hypomanic episode, schizophrenia spectrum disorders, organic mental disorders, or intellectual disabilities;
2. Having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt) as assessed by K-SADS;
3. Having been enrolled in any other clinical trial investigational products within one month at the entry of the study;
4. Initiation of or change in antidepressant medication within past 4 weeks;
5. Having been or is currently receiving any structured psychotherapy;
6. With hearing or speech deficit;
7. Night shift worker;
8. Trans-meridian flight across at least two time zones in the past 3 months and during the study;
9. Presence of an eye disease, e.g., retinal blindness, severe cataract, glaucoma.

Where it's running

  • The Chinese University of Hong Kong
    Hong Kong, Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Longitudinal look at how lasting TMS benefits can be predicted for depression

    This study follows people with major depressive disorder who responded to prior rTMS to see what factors predict how long their response lasts.

    Recruiting Hospital Center Guillaume Régnier · Rennes · NCT07684911

  • Assessing brain and cognitive changes after a new depression treatment

    This study is testing whether a new brain stimulation treatment can improve mood and thinking skills in people with moderate depression.

    Recruiting University Hospital of North Norway · Tromsø · NCT06534684

  • Understanding the impact of mood disorders and treatment responses

    This study is trying to learn more about how people with depression and bipolar disorder respond to treatment by talking to them weekly for up to 12 weeks to improve future care and predict how well medications might work.

    Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06462196

  • Using intermittent theta-burst stimulation to treat major depression

    This study is testing if a gentler form of brain stimulation can help people with major depression feel better, especially those who haven't found relief with regular medications.

    Recruiting The Hong Kong Polytechnic University · Hong Kong · NCT06392867

  • Bright Light Therapy for Depression

    This study tests if Bright Light Therapy can help people with unipolar and bipolar depression feel better, and whether adding lifestyle changes can make it work even better.

    Recruiting at 2 sites Universiteit Leiden · Eindhoven and 1 other locations · NCT05958940

  • Using fMRI-neurofeedback to treat depression

    This study is testing if adding brain training using fMRI-neurofeedback to regular treatment can help adults with depression feel better compared to just getting standard care.

    Recruiting at 3 sites Maastricht University Medical Center · Maastricht and 2 other locations · NCT05640089

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.